Top Markets
Coin of the day
Vasamed, Inc. Vasamed, Inc.

Vasamed, Inc.

VSMD
Hisse Senetlerindeki Sıralama #42568
Vasamed, Inc. specializes in the development, manufacturing, licensing, and... Vasamed, Inc. specializes in the development, manufacturing, licensing, and distribution of a comprehensive suite of products, software solutions, and services focused on the assessment and management of circulatory health throughout the United States. Key among its offerings is the SensiLase PAD-IQ, a device designed to measure skin perfusion pressure, conduct pulse volume recordings, and calculate the Ankle-Brachial Index utilizing Doppler-derived pressure readings. The company also provides advanced Wound Imaging & SmartDraw systems for precise wound measurement. Additionally, Vasamed offers the PAD-IQ Studycast, a platform that facilitates the rapid and secure transmission of diagnostic test results to vascular specialists. This enables prompt interpretation of findings and supports timely, medically indicated therapeutic interventions. For safeguarding its equipment, the company also supplies a custom carrying case for the PAD-IQ system. Vasamed caters to both clinicians and patients, and has been operating since its founding in 1988. Its corporate headquarters are located in Eden Prairie, Minnesota.
Hisse Fiyatı
$0.0001
Son senkronizasyon: 2026-08-11
Piyasa Değeri
$802.00
Değişim (1 gün)
0.00%
Değişim (1 yıl)
0.00%
Ülke
US
Ticaret Vasamed, Inc. (VSMD)

Kategori

Vasamed, Inc. (VSMD) için kazanç
2026 itibarıyla kazanç TTM: 0
Vasamed, Inc. şirketinin en son finansal raporlarına göre, mevcut kazancı 0'dir. 2026 yılında şirket 0 kazanç elde etti, bu 2026 yılındaki 0 kazanca göre önceki yıla eşit. Bu sayfada gösterilen kazanç, faiz ve vergiler öncesi kazançtır; yani EBIT.
Vasamed, Inc. için kazanç geçmişi 2026 - 2026
Her yılın sonundaki kazanç
Yıl Kazanç Değiştir
Sağlanan tarihler için yeterli veri yok.
Benzer şirketler veya rakipler için kazanç
Şirket Kazanç Kazanç Farkı Ülke
$3.81B -
US
$4.11B -
FR
- -
JP
$1.59B -
US
- -
CH